Charlotte Cosemans
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Charlotte Cosemans has a total of 112 co-authors. Here are the top co-authors by number of shared publications:
- Michelle Plusquin
Hasselt University
12 shared publications Tim S. Nawrot
Centre for Environmental Sciences, Environmental and Molecular Epidemiology, Hasselt University, Agoralaan Building D, 3590 Diepenbeek, Belgium; Department of Public Health & Primary Care, Leuven University, Leuven, Belgium
8 shared publicationsMichelle Plusquin
Centre for Environmental Sciences, Environmental and Molecular Epidemiology, Hasselt University, Agoralaan Building D, 3590 Diepenbeek, Belgium
5 shared publicationsCongrong Wang
Centre for Environmental Sciences, UHasselt, Diepenbeek, Belgium
4 shared publicationsKaren Smeets
Centre for Environmental Sciences, Hasselt University, 3590 Diepenbeek, Belgium
4 shared publicationsBram G. Janssen
Centre for Environmental Sciences, Hasselt University, 3590 Diepenbeek, Belgium
3 shared publications
Latest Publications
- Open Access
- 19 May 2026
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 23 (5) , 672
Micro and Nanoplastics and Obstetric Outcomes in Humans and Animals: A Systematic Review
Background: Micro- and nano-plastics (MNPs) are pervasive environmental contaminants that accumulate in various tissues, including the placenta. Experimental and clinical studies suggest potential cytotoxic, oxidative, and inflammatory effects that may lead to placental dysfunction and adverse obstetric outcomes. However, high-quality evidence on the clinical relevance of MNPs exposure during pregnancy remains scarce, underscoring the need for systematic evaluation of their impact on maternal and fetal health. Methods: The databases PubMed, ScienceDirect, CENTRAL, Embase, MDPI and Google Scholar were searched for studies published up to September 2025 investigating the relationship between MNPs and obstetric outcomes. Results: Twelve studies were included in this review, with half employing an observational design in human subjects and the other half using experimental studies in murine models. Although the available evidence is limited, there are studies reporting the association between MNPs exposure and premature birth, low birth weight, intrauterine growth restriction, and miscarriage. The most prevalent polymer detected was polyethylene, and the most commonly used MNPs detection techniques were Raman microspectroscopy, digital microscopy, Fourier Transform Infrared, and Pyrolysis gas chromatography-mass spectrometry. Conclusions: This systematic review summarizes current limited insights on the potential effects of MNPs on obstetric outcomes, highlighting possible associations with low gestational age, low birth weight, intrauterine growth restriction, and miscarriage. Findings do not allow causal inference due to heterogeneity in study design, exposure assessment, contamination control, and analytical methodologies.
- 19 May 2026
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 23 (5) , 672
Open AccessMicro and Nanoplastics and Obstetric Outcomes in Humans and Animals: A Systematic Review
Background: Micro- and nano-plastics (MNPs) are pervasive environmental contaminants that accumulate in various tissues, including the placenta. Experimental and clinical studies suggest potential cytotoxic, oxidative, and inflammatory effects that may lead to placental dysfunction and adverse obstetric outcomes. However, high-quality evidence on the clinical relevance of MNPs exposure during pregnancy remains scarce, underscoring the need for systematic evaluation of their impact on maternal and fetal health. Methods: The databases PubMed, ScienceDirect, CENTRAL, Embase, MDPI and Google Scholar were searched for studies published up to September 2025 investigating the relationship between MNPs and obstetric outcomes. Results: Twelve studies were included in this review, with half employing an observational design in human subjects and the other half using experimental studies in murine models. Although the available evidence is limited, there are studies reporting the association between MNPs exposure and premature birth, low birth weight, intrauterine growth restriction, and miscarriage. The most prevalent polymer detected was polyethylene, and the most commonly used MNPs detection techniques were Raman microspectroscopy, digital microscopy, Fourier Transform Infrared, and Pyrolysis gas chromatography-mass spectrometry. Conclusions: This systematic review summarizes current limited insights on the potential effects of MNPs on obstetric outcomes, highlighting possible associations with low gestational age, low birth weight, intrauterine growth restriction, and miscarriage. Findings do not allow causal inference due to heterogeneity in study design, exposure assessment, contamination control, and analytical methodologies.
- Open Access
- 3 April 2026
- Published by Elsevier in Environment International
- Vol. 211, 110238
Early-life lipid programming: Environmental and biological drivers of neonatal cholesterol
- 3 April 2026
- Published by Elsevier in Environment International
- Vol. 211, 110238
Open AccessEarly-life lipid programming: Environmental and biological drivers of neonatal cholesterol
- Open Access
Effectiveness of Baby-Friendly Hospital Initiative on Early Initiation and Exclusive Breastfeeding Practice: Systematic Review and Meta-Analysis
Background: The Baby-Friendly Hospital Initiative (BFHI) promotes, protects, and supports optimal breastfeeding through facility-based strategies. While prior studies have examined individual BFHI components in specific contexts, global evidence on its overall impact remains limited. This systematic review and meta-analysis aimed to evaluate the BFHI’s effectiveness in improving early initiation and exclusive breastfeeding practices worldwide. Methods: A comprehensive search was conducted in PubMed, Web of Science, Scopus, and Google for English-language studies. Eligible studies included randomized controlled trials (RCTs), cluster RCTs, and quasi-experimental designs assessing BFHI’s effect on breastfeeding outcomes. Random-effects meta-analysis models were used to estimate the pooled effects with 95% confidence intervals (CI). Heterogeneity was assessed using I2 statistics and p-values. Study quality was appraised using the GRADE approach. Results: Thirty studies met the inclusion criteria. The BFHI was associated with increased early initiation of breastfeeding (pooled RR 1.43; 95% CI: 1.12–1.81; I2 = 97.1%). Positive associations were also observed for exclusive breastfeeding at four months (RR 1.18, 95% CI: 1.08–1.29; I2 = 61.7%) and at six months (RR 1.56, 95% CI: 1.14–2.14; I2 = 82.8%). Substantial heterogeneity reflected variability in study design, BFHI implementation fidelity, and context. Conclusions: Our findings suggest that the BFHI is effective in improving breastfeeding practices globally. However, study variability and partial implementation may limit the generalizability of results. High-quality RCTs assessing full BFHI implementation are needed to strengthen evidence and guide global maternal–child health policy.
Open AccessEffectiveness of Baby-Friendly Hospital Initiative on Early Initiation and Exclusive Breastfeeding Practice: Systematic Review and Meta-Analysis
Background: The Baby-Friendly Hospital Initiative (BFHI) promotes, protects, and supports optimal breastfeeding through facility-based strategies. While prior studies have examined individual BFHI components in specific contexts, global evidence on its overall impact remains limited. This systematic review and meta-analysis aimed to evaluate the BFHI’s effectiveness in improving early initiation and exclusive breastfeeding practices worldwide. Methods: A comprehensive search was conducted in PubMed, Web of Science, Scopus, and Google for English-language studies. Eligible studies included randomized controlled trials (RCTs), cluster RCTs, and quasi-experimental designs assessing BFHI’s effect on breastfeeding outcomes. Random-effects meta-analysis models were used to estimate the pooled effects with 95% confidence intervals (CI). Heterogeneity was assessed using I2 statistics and p-values. Study quality was appraised using the GRADE approach. Results: Thirty studies met the inclusion criteria. The BFHI was associated with increased early initiation of breastfeeding (pooled RR 1.43; 95% CI: 1.12–1.81; I2 = 97.1%). Positive associations were also observed for exclusive breastfeeding at four months (RR 1.18, 95% CI: 1.08–1.29; I2 = 61.7%) and at six months (RR 1.56, 95% CI: 1.14–2.14; I2 = 82.8%). Substantial heterogeneity reflected variability in study design, BFHI implementation fidelity, and context. Conclusions: Our findings suggest that the BFHI is effective in improving breastfeeding practices globally. However, study variability and partial implementation may limit the generalizability of results. High-quality RCTs assessing full BFHI implementation are needed to strengthen evidence and guide global maternal–child health policy.
- Open Access
- 24 April 2025
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1585347
Editorial: The impact of exposure to environmental chemicals, pharmaceuticals and particles via human breast milk: a focus on health effects and underlying mechanisms
Breastfeeding is widely recognized as the optimal source of nutrition for ensuring the health and wellbeing of infants, providing essential nutrients and antibodies that strengthen their immune system and support neurodevelopment (1)(2)(3). However, the presence of environmental pollutants and pharmaceuticals in human milk could raise concerns regarding potential adverse health effects on nursing infants, as it has been shown that both breastfeeding mothers and healthcare providers are concerned about the transfer of these exogenous substances in milk (4). This research topic aimed to explore the impact of exposure to various environmental chemicals, pharmaceuticals, and particles through human milk, focusing on understanding their biological effects on children and adolescents. The accepted studies in this research topic comprise a mini review, two brief research reports, and four original research papers, providing insights into the complexities of maternal transfer of these substances and emphasizing the need for continued research and funding to safeguard maternal and infant health. human milk and the potential risk to infants. Valsartan was undetectable in all milk samples, while sacubitril and its active metabolite LBQ657 were present at low concentrations, with a combined RID of <0.25%, well below the safety threshold of 10%. These findings suggest minimal exposure through breastfeeding, indicating a low risk to infants. Naidoo et al. investigated the impact of prenatal exposure to tenofovir diphosphate (TFV-DP) containing pre-exposure prophylaxis (PrEP) on growth metrics in HIVunexposed, breastfed African infants and found no significant differences in weight, length, or head circumference Z-scores over 18 months. These findings suggest that prenatal exposure to TFV-DP does not affect early childhood growth. While previous studies specifically examine pharmaceuticals in human milk, mothers can be worried about the transfer of vaccine particles into milk. Despite a systematic review reporting no severe COVID-19 vaccine-related adverse effects in either mothers or nursing infants and no significant transfer of vaccine components into breast milk (6), vaccine hesitancy among breastfeeding women seems to remain high. Simsekoglu et al. examined COVID-19 vaccine hesitancy and attitudes among pregnant and breastfeeding women in Turkey. While participants showed a high level of vaccine hesitation, their overall attitude toward vaccination was positive. Factors such as working status, influenza vaccination history, smoking, and chronic disease influenced hesitancy and attitudes, highlighting the need for targeted strategies to address concerns in future pandemics (7).Lastly, one study focused on environmental particles in human milk. Cosemans et al. showed for the first time that traffic-related particulate matter, such as black carbon particles, was detected in human milk and found an association with ambient air pollution concentrations at the maternal residential address.This study reported a novel pathway through which these particles can directly enter the infant's system, in addition to being exposed via inhalation. It has been previously established that prenatal exposure to particulate matter is linked to health outcomes in children, such as neurodevelopment (8), kidney function
- 24 April 2025
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1585347
Open AccessEditorial: The impact of exposure to environmental chemicals, pharmaceuticals and particles via human breast milk: a focus on health effects and underlying mechanisms
Breastfeeding is widely recognized as the optimal source of nutrition for ensuring the health and wellbeing of infants, providing essential nutrients and antibodies that strengthen their immune system and support neurodevelopment (1)(2)(3). However, the presence of environmental pollutants and pharmaceuticals in human milk could raise concerns regarding potential adverse health effects on nursing infants, as it has been shown that both breastfeeding mothers and healthcare providers are concerned about the transfer of these exogenous substances in milk (4). This research topic aimed to explore the impact of exposure to various environmental chemicals, pharmaceuticals, and particles through human milk, focusing on understanding their biological effects on children and adolescents. The accepted studies in this research topic comprise a mini review, two brief research reports, and four original research papers, providing insights into the complexities of maternal transfer of these substances and emphasizing the need for continued research and funding to safeguard maternal and infant health. human milk and the potential risk to infants. Valsartan was undetectable in all milk samples, while sacubitril and its active metabolite LBQ657 were present at low concentrations, with a combined RID of <0.25%, well below the safety threshold of 10%. These findings suggest minimal exposure through breastfeeding, indicating a low risk to infants. Naidoo et al. investigated the impact of prenatal exposure to tenofovir diphosphate (TFV-DP) containing pre-exposure prophylaxis (PrEP) on growth metrics in HIVunexposed, breastfed African infants and found no significant differences in weight, length, or head circumference Z-scores over 18 months. These findings suggest that prenatal exposure to TFV-DP does not affect early childhood growth. While previous studies specifically examine pharmaceuticals in human milk, mothers can be worried about the transfer of vaccine particles into milk. Despite a systematic review reporting no severe COVID-19 vaccine-related adverse effects in either mothers or nursing infants and no significant transfer of vaccine components into breast milk (6), vaccine hesitancy among breastfeeding women seems to remain high. Simsekoglu et al. examined COVID-19 vaccine hesitancy and attitudes among pregnant and breastfeeding women in Turkey. While participants showed a high level of vaccine hesitation, their overall attitude toward vaccination was positive. Factors such as working status, influenza vaccination history, smoking, and chronic disease influenced hesitancy and attitudes, highlighting the need for targeted strategies to address concerns in future pandemics (7).Lastly, one study focused on environmental particles in human milk. Cosemans et al. showed for the first time that traffic-related particulate matter, such as black carbon particles, was detected in human milk and found an association with ambient air pollution concentrations at the maternal residential address.This study reported a novel pathway through which these particles can directly enter the infant's system, in addition to being exposed via inhalation. It has been previously established that prenatal exposure to particulate matter is linked to health outcomes in children, such as neurodevelopment (8), kidney function
- Open Access
- 7 August 2024
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 12, 1437328
Quantification of ADHD medication in biological fluids of pregnant and breastfeeding women with liquid chromatography: a comprehensive review
Attention Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder that has long been considered a concern only in the pediatric population. However, symptoms often sustain into adulthood and may require medication. For women with ADHD, this also means dealing with the disorder during the reproductive period. Medication safety during pregnancy and breastfeeding is a critical concern, and the potential transfer of ADHD medication to infants remains a topic of scientific interest. The quantification of ADHD medications in both maternal blood and breast milk are vital for understanding their pharmacokinetics and potential exposure risks for (nursing) infants. This review aims (1) to compile and critically assess existing research on the transfer of ADHD medications into breast milk and the potential implications for nursing infants and (2) to provide a comprehensive overview and discussion of the literature regarding the quantification of methylphenidate, amphetamine, atomoxetine, viloxazine, guanfacine, clonidine and bupropion in the blood, urine, oral fluid, and breast milk with liquid chromatography. A literature search was conducted using PubMed, Scopus, and Web of Science, to identify relevant articles published from January 2014 up to December 2023. We illustrate the lack of methods to simultaneously monitor multiple ADHD medications as well as the lack of developed methods for breast milk. Finally, we highlight the need for continued research to refine our understanding of medication transfer into breast milk and potential risks, and to develop clinical guidelines to support mothers with ADHD in making informed choices regarding medication use during pregnancy and lactation.
- 7 August 2024
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 12, 1437328
Open AccessQuantification of ADHD medication in biological fluids of pregnant and breastfeeding women with liquid chromatography: a comprehensive review
Attention Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder that has long been considered a concern only in the pediatric population. However, symptoms often sustain into adulthood and may require medication. For women with ADHD, this also means dealing with the disorder during the reproductive period. Medication safety during pregnancy and breastfeeding is a critical concern, and the potential transfer of ADHD medication to infants remains a topic of scientific interest. The quantification of ADHD medications in both maternal blood and breast milk are vital for understanding their pharmacokinetics and potential exposure risks for (nursing) infants. This review aims (1) to compile and critically assess existing research on the transfer of ADHD medications into breast milk and the potential implications for nursing infants and (2) to provide a comprehensive overview and discussion of the literature regarding the quantification of methylphenidate, amphetamine, atomoxetine, viloxazine, guanfacine, clonidine and bupropion in the blood, urine, oral fluid, and breast milk with liquid chromatography. A literature search was conducted using PubMed, Scopus, and Web of Science, to identify relevant articles published from January 2014 up to December 2023. We illustrate the lack of methods to simultaneously monitor multiple ADHD medications as well as the lack of developed methods for breast milk. Finally, we highlight the need for continued research to refine our understanding of medication transfer into breast milk and potential risks, and to develop clinical guidelines to support mothers with ADHD in making informed choices regarding medication use during pregnancy and lactation.
- 27 May 2024
- Published by Springer Nature in International Journal of Obesity
- Vol. 48 (8) , 1140-1147
Exploring mitochondrial heteroplasmy in neonates: implications for growth patterns and overweight in the first years of life
Background Mitochondrial heteroplasmy reflects genetic diversity within individuals due to the presence of varying mitochondrial DNA (mtDNA) sequences, possibly affecting mitochondrial function and energy production in cells. Rapid growth during early childhood is a critical development with long-term implications for health and well-being. In this study, we investigated if cord blood mtDNA heteroplasmy is associated with rapid growth at 6 and 12 months and overweight in childhood at 4–6 years. Methods This study included 200 mother-child pairs of the ENVIRONAGE birth cohort. Whole mitochondrial genome sequencing was performed to determine mtDNA heteroplasmy levels (in variant allele frequency; VAF) in cord blood. Rapid growth was defined for each child as the difference between WHO-SD scores of predicted weight at either 6 or 12 months and birth weight. Logistic regression models were used to determine the association of mitochondrial heteroplasmy with rapid growth and childhood overweight. Determinants of relevant cord blood mitochondrial heteroplasmies were identified using multiple linear regression models. Results One % increase in VAF of cord blood MT-D-Loop16362T > C heteroplasmy was associated with rapid growth at 6 months (OR = 1.03; 95% CI: 1.01–1.05; p = 0.001) and 12 months (OR = 1.02; 95% CI: 1.00–1.03; p = 0.02). Furthermore, this variant was associated with childhood overweight at 4–6 years (OR = 1.01; 95% CI 1.00–1.02; p = 0.05). Additionally, rapid growth at 6 months (OR = 3.00; 95% CI: 1.49–6.14; p = 0.002) and 12 months (OR = 4.05; 95% CI: 2.06–8.49; p < 0.001) was also associated with childhood overweight at 4–6 years. Furthermore, we identified maternal age, pre-pregnancy BMI, maternal education, parity, and gestational age as determinants of cord blood MT-D-Loop16362T > C heteroplasmy. Conclusions Our findings, based on mitochondrial DNA genotyping, offer insights into the molecular machinery leading to rapid growth in early life, potentially explaining a working mechanism of the development toward childhood overweight.
- 27 May 2024
- Published by Springer Nature in International Journal of Obesity
- Vol. 48 (8) , 1140-1147
Exploring mitochondrial heteroplasmy in neonates: implications for growth patterns and overweight in the first years of life
Background Mitochondrial heteroplasmy reflects genetic diversity within individuals due to the presence of varying mitochondrial DNA (mtDNA) sequences, possibly affecting mitochondrial function and energy production in cells. Rapid growth during early childhood is a critical development with long-term implications for health and well-being. In this study, we investigated if cord blood mtDNA heteroplasmy is associated with rapid growth at 6 and 12 months and overweight in childhood at 4–6 years. Methods This study included 200 mother-child pairs of the ENVIRONAGE birth cohort. Whole mitochondrial genome sequencing was performed to determine mtDNA heteroplasmy levels (in variant allele frequency; VAF) in cord blood. Rapid growth was defined for each child as the difference between WHO-SD scores of predicted weight at either 6 or 12 months and birth weight. Logistic regression models were used to determine the association of mitochondrial heteroplasmy with rapid growth and childhood overweight. Determinants of relevant cord blood mitochondrial heteroplasmies were identified using multiple linear regression models. Results One % increase in VAF of cord blood MT-D-Loop16362T > C heteroplasmy was associated with rapid growth at 6 months (OR = 1.03; 95% CI: 1.01–1.05; p = 0.001) and 12 months (OR = 1.02; 95% CI: 1.00–1.03; p = 0.02). Furthermore, this variant was associated with childhood overweight at 4–6 years (OR = 1.01; 95% CI 1.00–1.02; p = 0.05). Additionally, rapid growth at 6 months (OR = 3.00; 95% CI: 1.49–6.14; p = 0.002) and 12 months (OR = 4.05; 95% CI: 2.06–8.49; p < 0.001) was also associated with childhood overweight at 4–6 years. Furthermore, we identified maternal age, pre-pregnancy BMI, maternal education, parity, and gestational age as determinants of cord blood MT-D-Loop16362T > C heteroplasmy. Conclusions Our findings, based on mitochondrial DNA genotyping, offer insights into the molecular machinery leading to rapid growth in early life, potentially explaining a working mechanism of the development toward childhood overweight.
- 4 April 2024
- Published by Elsevier in Environmental Research
- Vol. 252 (Pt 1) , 118879
Prenatal particulate matter exposure is linked with neurobehavioural development in early life
- 4 April 2024
- Published by Elsevier in Environmental Research
- Vol. 252 (Pt 1) , 118879
Prenatal particulate matter exposure is linked with neurobehavioural development in early life
- Open Access
- 17 January 2024
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 11, 1333969
Black carbon particles in human breast milk: assessing infant’s exposure
Background/Aim: Human breast milk is the recommended source of nutrition for infants due to its complex composition and numerous benefits, including a decline in infection rates in childhood and a lower risk of obesity. Hence, it is crucial that environmental pollutants in human breast milk are minimized. Exposure to black carbon (BC) particles has adverse effects on health; therefore, this pilot study investigates the presence of these particles in human breast milk.Methods: BC particles from ambient exposure were measured in eight human breast milk samples using a white light generation under femtosecond illumination. The carbonaceous nature of the particles was confirmed with BC fingerprinting. Ambient air pollution exposures (PM2.5, PM10, and NO2) were estimated using a spatial interpolation model based on the maternal residential address. Spearman rank correlation coefficients were obtained to assess the association between human breast milk’s BC load and ambient air pollution exposure.Results: BC particles were found in all human breast milk samples. BC loads in human breast milk were strongly and positively correlated with recent (i.e., 1 week) maternal residential NO2 (r = 0.79; p = 0.02) exposure and medium-term (i.e., 1 month) PM2.5 (r = 0.83; p = 0.02) and PM10 (r = 0.93; p = 0.002) exposure.Conclusion: For the first time, we showed the presence of BC particles in human breast milk and found a robust association with ambient air pollution concentrations. Our findings present a pioneering insight into a novel pathway through which combustion-derived air pollution particles can permeate the delicate system of infants.
- 17 January 2024
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 11, 1333969
Open AccessBlack carbon particles in human breast milk: assessing infant’s exposure
Background/Aim: Human breast milk is the recommended source of nutrition for infants due to its complex composition and numerous benefits, including a decline in infection rates in childhood and a lower risk of obesity. Hence, it is crucial that environmental pollutants in human breast milk are minimized. Exposure to black carbon (BC) particles has adverse effects on health; therefore, this pilot study investigates the presence of these particles in human breast milk.Methods: BC particles from ambient exposure were measured in eight human breast milk samples using a white light generation under femtosecond illumination. The carbonaceous nature of the particles was confirmed with BC fingerprinting. Ambient air pollution exposures (PM2.5, PM10, and NO2) were estimated using a spatial interpolation model based on the maternal residential address. Spearman rank correlation coefficients were obtained to assess the association between human breast milk’s BC load and ambient air pollution exposure.Results: BC particles were found in all human breast milk samples. BC loads in human breast milk were strongly and positively correlated with recent (i.e., 1 week) maternal residential NO2 (r = 0.79; p = 0.02) exposure and medium-term (i.e., 1 month) PM2.5 (r = 0.83; p = 0.02) and PM10 (r = 0.93; p = 0.002) exposure.Conclusion: For the first time, we showed the presence of BC particles in human breast milk and found a robust association with ambient air pollution concentrations. Our findings present a pioneering insight into a novel pathway through which combustion-derived air pollution particles can permeate the delicate system of infants.
- Open Access
- 8 November 2023
- Published by Springer Nature in Research Square
Exploring Mitochondrial Heteroplasmy in Neonates: Implications for Growth Patterns in the First Years of Life
Background: Mitochondrial heteroplasmy reflects genetic diversity within individuals due to the presence of varying mitochondrial DNA (mtDNA) sequences, possibly affecting mitochondrial function and energy production in cells. Rapid growth during early childhood is a critical development with long-term implications for health and well-being. In this study, we investigated if cord blood mtDNA heteroplasmy is associated with rapid growth at six and 12 months and overweight in childhood at four to six years. Methods: This study included 200 mother-child pairs of the ENVIRONAGE birth cohort. Whole mitochondrial genome sequencing was performed to determine mtDNA heteroplasmy levels (in variant allele frequency; VAF) in cord blood. Rapid growth was defined for each child as the difference between WHO-SD scores of predicted weight at either six or 12 months and birth weight. Logistic regression models were used to determine the association of mitochondrial heteroplasmy with rapid growth and childhood overweight. Determinants of relevant cord blood mitochondrial heteroplasmies were identified using multiple linear regression models. Results: One % increase in VAF of cord blood MT-D-Loop16362T>C heteroplasmy was associated with rapid growth at six (OR=1.03; 95% CI: 1.01 to 1.05; p=0.001) and 12 months (OR=1.02; 95% CI: 1.00 to 1.03; p=0.02). Furthermore, this variant was associated with childhood overweight at four to six years (OR=1.01; 95% CI 1.00 to 1.02; p=0.05). Additionally, rapid growth at six (OR=3.00; 95% CI: 1.49 to 6.14; p=0.002) and 12 months (OR=4.05; 95% CI: 2.06 to 8.49; p16362T>C heteroplasmy. Conclusions: Our findings, based on mitochondrial DNA genotyping, offer insights into the molecular machinery leading to rapid growth in early life, potentially explaining a working mechanism of the development towards childhood overweight.
- 8 November 2023
- Published by Springer Nature in Research Square
Open AccessExploring Mitochondrial Heteroplasmy in Neonates: Implications for Growth Patterns in the First Years of Life
Background: Mitochondrial heteroplasmy reflects genetic diversity within individuals due to the presence of varying mitochondrial DNA (mtDNA) sequences, possibly affecting mitochondrial function and energy production in cells. Rapid growth during early childhood is a critical development with long-term implications for health and well-being. In this study, we investigated if cord blood mtDNA heteroplasmy is associated with rapid growth at six and 12 months and overweight in childhood at four to six years. Methods: This study included 200 mother-child pairs of the ENVIRONAGE birth cohort. Whole mitochondrial genome sequencing was performed to determine mtDNA heteroplasmy levels (in variant allele frequency; VAF) in cord blood. Rapid growth was defined for each child as the difference between WHO-SD scores of predicted weight at either six or 12 months and birth weight. Logistic regression models were used to determine the association of mitochondrial heteroplasmy with rapid growth and childhood overweight. Determinants of relevant cord blood mitochondrial heteroplasmies were identified using multiple linear regression models. Results: One % increase in VAF of cord blood MT-D-Loop16362T>C heteroplasmy was associated with rapid growth at six (OR=1.03; 95% CI: 1.01 to 1.05; p=0.001) and 12 months (OR=1.02; 95% CI: 1.00 to 1.03; p=0.02). Furthermore, this variant was associated with childhood overweight at four to six years (OR=1.01; 95% CI 1.00 to 1.02; p=0.05). Additionally, rapid growth at six (OR=3.00; 95% CI: 1.49 to 6.14; p=0.002) and 12 months (OR=4.05; 95% CI: 2.06 to 8.49; p16362T>C heteroplasmy. Conclusions: Our findings, based on mitochondrial DNA genotyping, offer insights into the molecular machinery leading to rapid growth in early life, potentially explaining a working mechanism of the development towards childhood overweight.